IP Library Granted Patent US 11,756,690
Granted Patent B2
US 11,756,690 · App. 17/933,176 · Granted Sep 12, 2023

Systems and methods for estimating hemodynamic forces acting on plaque and monitoring risk

Inventors: Bon-Kwon Koo (Seoul, KR); Gilwoo Choi (Mountain View, CA); Hyun Jin Kim (San Mateo, CA); Charles A. Taylor (Atherton, CA)
Assignee: HeartFlow, Inc.
G16H50/50A61B5/026A61B5/02007A61B5/0215G16H50/20G16H50/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,756,690
App. No.
17/933,176
Granted
Sep 12, 2023
Kind
B2
Abstract

Computer-implemented methods are disclosed for estimating values of hemodynamic forces acting on plaque or lesions. One method includes: receiving one or more patient-specific parameters of at least a portion of a patient's vasculature that is prone to plaque progression, rupture, or erosion; constructing a patient-specific geometric model of at least a portion of a patient's vasculature that is prone to plaque progression, rupture, or erosion, using the received one or more patient-specific parameters; estimating, using one or more processors, the values of hemodynamic forces at one or more points on the patient-specific geometric model, using the patient-specific parameters and geometric model by measuring, deriving, or obtaining one or more of a pressure gradient and a radius gradient; and outputting the estimated values of hemodynamic forces to an electronic storage medium. Systems and computer readable media for executing these methods are also disclosed.

Claims (49)

1. A computer-implemented method for monitoring hemodynamic risk of a patient, the method comprising:

acquiring a patient-specific model of blood flow through at least a portion of a patient's vasculature;

obtaining a current patient-specific parameter of the patient;

determining a current hemodynamic characteristic of the patient based on the patient-specific model and the current patient-specific parameter of the patient;

obtaining a maximum allowable hemodynamic characteristic of the patient;

comparing the current hemodynamic characteristic with the maximum allowable hemodynamic characteristic;

determining, based on the comparing, whether the current hemodynamic characteristic includes an abnormal value; and

in response to determining that the current hemodynamic characteristic includes an abnormal value, producing a warning indicative of the abnormal value.

2. The computer-implemented method of claim 1 , wherein the current patient-specific parameter of the patient is acquired during exercise by the patient.

3. The computer-implemented method of claim 1 , wherein the current patient-specific parameter of the patient is acquired by a mobile device associated with the patient.

4. The computer-implemented method of claim 1 , wherein the patient-specific model is a geometric model.

5. The computer-implemented method of claim 1 , wherein the current patient-specific parameter includes a biophysical characteristic or a hemodynamic characteristic.

6. The computer-implemented method of claim 1 , wherein determining the current hemodynamic characteristic of the patient includes:

determining a simplified hemodynamic characteristic for at least a first portion of the patient-specific model; and

based on the determined simplified hemodynamic characteristic, determining a hemodynamic characteristic for a second portion of the patient-specific model, for which the simplified hemodynamic characteristic is unknown.

7. The computer-implemented method of claim 6 , wherein determining the hemodynamic characteristic for the second portion of the patient-specific model includes employing a machine learning algorithm trained, based on patient-specific parameters of other patients and hemodynamic characteristics associated with one or more portions of patient-specific models of the other patients, to determine the hemodynamic characteristic for various portions of a patient-specific geometric model.

8. The computer-implemented method of claim 1 , wherein obtaining the maximum allowable hemodynamic characteristic of the patient includes:

Obtaining a patient-specific exercise-induced physiological stress characteristic for the patient; and

based on the patient-specific exercise-induced physiological stress characteristic, determining the maximum allowable hemodynamic characteristic of the patient.

9. The computer-implemented method of claim 8 , wherein:

determining the maximum allowable hemodynamic characteristic of the patient includes inputting the patient-specific exercise-induced physiological stress characteristic into a trained machine learning algorithm; and

the trained machine learning algorithm is obtained based on one or more patient-specific parameters of a vascular system from each of a plurality of individuals with known values of hemodynamic forces.

10. The computer-implemented method of claim 8 , wherein obtaining the patient-specific exercise-induced physiological stress characteristic includes performing an exercise test on the patient.

11. The computer-implemented method of claim 8 , wherein the patient-specific exercise-induced physiological stress characteristic is determined based on patient medical records.

12. The computer-implemented method of claim 1 , wherein the warning includes a signal provided by a device associated with the patient or a physician.

13. The computer-implemented method of claim 1 , further comprising obtaining, for the patient, a geometric characteristic, a plaque characteristic, or a coronary dynamics characteristic.

14. The computer-implemented method of claim 1 , wherein the patient-specific model of blood flow includes blood flow through one or more of: a coronary vascular model, a cerebral vascular model, a peripheral vascular model, a hepatic vascular model, a renal vascular model, or a visceral vascular model.

15. The computer-implemented method of claim 1 , further comprising acquiring a digital representation of a patient-specific parameter using imaging, scanning, or measuring modalities.

16. A system for monitoring hemodynamic risk in a patient, the system comprising:

a data storage device storing instructions for monitoring hemodynamic risk in a patient; and

a processor operatively connected to the data storage device and configured to execute the instructions to perform a method, including:

acquiring a patient-specific model of blood flow through at least a portion of a patient's vasculature;

obtaining a current patient-specific parameter of the patient;

determining a current hemodynamic characteristic of the patient based on the patient-specific model and the current patient-specific parameter of the patient;

obtaining a maximum allowable hemodynamic characteristic of the patient;

comparing the current hemodynamic characteristic with the maximum allowable hemodynamic characteristic;

determining, based on the comparing, whether the current hemodynamic characteristic includes an abnormal value; and

in response to determining that the current hemodynamic characteristic includes an abnormal value, producing a warning indicative of the abnormal value.

17. The system of claim 16 , wherein the current patient-specific parameter of the patient is acquired during exercise by the patient.

18. The system of claim 16 , wherein the current patient-specific parameter of the patient is acquired by a mobile device associated with the patient.

19. A non-transitory computer readable medium for use on a computer system containing computer-executable programming instructions for a method for monitoring hemodynamic risk in a patient, the method comprising:

acquiring a patient-specific model of blood flow through at least a portion of a patient's vasculature;

obtaining a current patient-specific parameter of the patient;

determining a current hemodynamic characteristic of the patient based on the patient-specific model and the current patient-specific parameter of the patient;

obtaining a maximum allowable hemodynamic characteristic of the patient;

comparing the current hemodynamic characteristic with the maximum allowable hemodynamic characteristic;

determining, based on the comparing, whether the current hemodynamic characteristic includes an abnormal value; and

in response to determining that the current hemodynamic characteristic includes an abnormal value, producing a warning indicative of the abnormal value.

20. The non-transitory computer readable medium of claim 19 , wherein the current patient-specific parameter of the patient is acquired during exercise by the patient.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Sep 11, 2025
From: HAYFIN SERVICES LLP
To: HEARTFLOW, INC.
Reel/Frame 072876/0775 →
SECURITY INTEREST Recorded Jun 18, 2024
From: HEARTFLOW, INC.
To: HAYFIN SERVICES LLP
Reel/Frame 067775/0966 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 19, 2022
From: KOO, BON-KWON; CHOI, GILWOO; KIM, HYUN JIN; TAYLOR, CHARLES A.
To: HEARTFLOW, INC.
Reel/Frame 061136/0411 →
Continuity (5)
Continuation 16875607 · May 15, 2020
Continuation 15201010 · Jul 1, 2016
Continuation 15199305 · Jun 30, 2016
Provisional Application 62192314 · Jul 14, 2015
Related Publication 20230016104A1 · Jan 19, 2023
Cited By (17)
US 12,245,882 US 12,283,046 US 12,299,885 US 12,324,695 US 12,324,696 US 12,380,560 US 12,396,695 US 12,406,365 US 12,440,180 US 12,499,539 US 12,555,228 US 12,558,048 US 12,599,352 US 12,620,092 US 12,635,965 US 12,712,082 US 12,714,382